Cardiovascular Diabetology · 2017 · 55 citations · 35 references
MedicineCardiologyInternal MedicineClinical CardiologyClinical EpidemiologyDiabetologyCardiac Risk AssessmentCardiovascular DiseaseCardiovascular RiskCarotid Artery DiseaseDiabetes ManagementDiabetes MellitusAtherosclerotic Carotid StenosisCardiovascular Disease IncidenceCardiovascular Disease MortalityCarotid Artery DopplerCarotid Artery StenosisCarotid Artery UltrasoundDiabetes DurationDiabetes-related Complications
BACKGROUND: We aimed to investigate the impact of diabetes duration and carotid artery stenosis (CAS) on the occurrence of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM) without clinical cardiovascular disease. METHODS: A total of 2006 patients with T2DM, without clinical cardiovascular disease, aged >50 years, and who underwent baseline carotid Doppler ultrasound screening with regular follow-ups at the outpatient clinic of our diabetes center, were stratified into four subgroups according to diabetes duration and CAS degree. The primary outcomes included the occurrence of MACE, defined as fatal or nonfatal stroke and myocardial infarction, and all-cause mortality. RESULTS: The difference in the MACE incidence was significantly greater in patients with a longer diabetes duration (≥10 years) and significant CAS (50-69% luminal narrowing) (p < 0.001). Analysis of individual MACE components indicated a trend towards an increased incidence of stroke (p < 0.001), parallel to a longer diabetes duration and significant CAS. In contrast, the risk of myocardial infarction was significantly higher in patients with a diabetes duration <10 years and significant CAS (p = 0.039). Multivariate regression analysis showed that patients with both a longer diabetes duration and significant CAS demonstrated additive and very high risks of MACE (hazard ratio [HR], 2.07; 95% confidence interval [CI] 1.17-3.66; p = 0.012) and stroke (HR, 3.38; 95% CI 1.54-7.44; p = 0.002). CONCLUSIONS: The risk of MACE is significantly greater in patients with T2DM, without clinical cardiovascular disease, who have both a longer diabetes duration and significant CAS, compared with those who have a shorter duration and/or nonsignificant CAS.
35
Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa et al. · New England Journal of Medicine · 1998 · 7.1K citations · Full text
Guidelines for the Primary Prevention of Stroke
James F. Meschia, Cheryl Bushnell, Lynne T. Braun et al. · Stroke · 2014 · 2.7K citations · Full text
Classification and Diagnosis of Diabetes
Stefan S. Fajans · Medical Entomology and Zoology · 1990 · 2.4K citations